December 6, 2010 - A European court has struck a blow to Boston Scientific's alleged patent infringement case against OrbusNeich. The case is viewed by OrbusNeich as an unsuccessful retaliatory litigation effort to distract the marketplace from OrbusNeich's pending patent infringement and theft of trade secret case against Boston Scientific in the United States.

December 6, 2010 – A Windows 7-compatible version of an ECG management software system will be available in the second quarter of 2011. The Global ECG Management Software (GEMS 4.0) software, by CardioComm Solutions, will encompass the full line of arrhythmia monitoring modules. It will also have multiple report-sending options, along with easy-to-use, customizable workflow features.

December 6, 2010 – The U.S. Food and Drug Administration (FDA) has given conditional approval for a trial that will investigate the role of a device in reducing infarct size in patients with ST-elevation myocardial infarction (STEMI). The MINI-AMI trial will use the Impella 2.5, from Abiomed, for 24 hours following primary percutaneous intervention (PCI).

December 6, 2010 – A new stent shows favorable outcomes compared to bare metal stents (BMS) for treating coronary artery bifurcation lesions. Data for the Genous Stent, from OrbusNeich, was published online in the journal, Atherosclerosis.

December 6, 2010 – A panel of medical imaging experts discussed medical imaging appropriateness, ionizing radiation and efforts to curb overutilization, decrease radiation dose and educate patients.

December 3, 2010 – The U.S. Food and Drug Administration (FDA) has given conditional approval for an Investigational Device Exception (IDE) application for a system for treating coronary artery disease. The pivotal trial will look at the Tryton Side Branch Stent.